⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GTBP News
GT Biopharma Inc. Common Stock
Immuno-Oncology Emerges as a Major Force in the Global Cancer Treatment Market
globenewswire.com
GTBP
MRNA
IOVA
GMAB
PFE
GT Biopharma Selected for Oral Presentation at the SITC 2026 Annual Meeting
globenewswire.com
GTBP
Form 8-K
sec.gov
PDSB
BMY
GTBP
VSTM
Form 8-K
sec.gov
GTBP
Form 8-K
sec.gov
GTBP
GT Biopharma Announces Potential New Indication for GTB-5550, a B7-H3-Targeted Natural Killer (NK) Cell Engager, for Multiple Myeloma
globenewswire.com
GTBP
Form 8-K
sec.gov
GTBP
GT Biopharma to Host Live Company Presentation on the Development of TriKE® Platform for Cancer Treatment, September 11, 2026
globenewswire.com
GTBP
Form 8-K
sec.gov
GTBP
Form 8-K
sec.gov
GTBP